Homoeopathy blasted by legislators in Germany
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Germany should revoke the ‘medicinal’ status it applies to homoeopathic products so they no longer qualify for reimbursement by the country’s statutory health insurance system, leading representatives of Germany’s legislature have argued.
You may also be interested in...
German Industry Tries To Nip Homeopathy Debate In The Bud As France Decides In Favour Of De-Reimbursement
As France decides to de-reimburse homeopathic medicines, discussions about whether this should be applied to Germany are being re-opened by politicians and high-profile representatives from the country's statutory health insurance system. Industry has responded by saying "no" to de-reimbursement, as the German system allows consumers to choose between insurers based on their views of homeopathy.
Pharmaceutical Society Of Australia Wants Pharmacy To ‘Draw A Line In The Sand’ And Stop Supplying Homeopathy
The Pharmaceutical Society of Australia has called on the country's pharmacy banner and buying groups to help remove homeopathic products from the shelves of Australian community pharmacies, thereby joining an international chorus of voices that has emerged over the last year questioning the efficacy of these treatments.
French Public Throw Support Behind Homoeopathic Reimbursement
Homeopathy continues to come under the spotlight in Europe, with France the latest country to examine the value of reimbursing such products.